Incidencia de infecciones sintomáticas y asintomáticas por virus dengue en Maracay, Venezuela: 2006-2007 / Incidence of symptomatic and asymptomatic dengue virus infections in Maracay, Venezuela: 2006-2007

Con el objetivo de estimar las tasas de incidencia de infecciones sintomáticas y asintomáticas por virus dengue (DENV) durante un año (octubre 2006-septiembre 2007) en cuatro barrios de Maracay (Venezuela) se realizó un estudio prospectivo consistente de visitas domiciliarias, tres veces por semana, para detectar casos de dengue y de encuestas serológicas semestrales para determinar infecciones asintomáticas probables por DENV. Los sujetos de estudio pertenecían a una cohorte de 2663 personas ≥5 años de edad. El diagnóstico confirmatorio de DENV se realizó mediante la reacción en cadena de la polimerasa con transcriptasa inversa (RT-PCR). Las pruebas serológicas se realizaron mediante el ensayo inmunoenzimático de captura de IgM anti-dengue (MAC-ELISA). Los resultados determinaron tasas de incidencia de 5,7 y 18,6 por 100 000 personas/día (p/d) para las infecciones sintomáticas y asintomáticas, respectivamente. La tasa de incidencia de las infecciones sintomáticas observada en las personas <15 años de edad fue significativamente mayor que la encontrada en los sujetos ≥15 años (15,8 versus 2,9 por 100 000 p/d). Por otro lado, las tasas de incidencia de las infecciones asintomáticas en ambos grupos de edad fueron similares (17,3 y 18,9 por 100 000 p/d, respectivamente). Se detectaron los cuatro serotipos del DENV en tres de los barrios estudiados. Se observó que la edad y la hiperendemicidad fueron probablemente los factores que más contribuyeron a la incidencia del dengue en los cuatro barrios investigados. Seguramente, las infecciones asintomáticas contribuyeron a incrementar la transmisión viral en el área de estudio.

The incidence rates of symptomatic and asymptomatic dengue virus (DENV) infections in four "barrios" of Maracay, Venezuela, during one-year (October 2006-September 2007) were estimated. A prospective study consisting of house visits three-times a week to detect dengue cases, and semiannual serological surveys to determine probable asymptomatic dengue virus (DENV) infections was conducted. The study subjects belonged to a cohort of 2,663 people ≥5 year-old. Confirmatory diagnosis of DENV infections was carried out by reverse-transcriptase polymerase chain reaction (RT-PCR). Serological surveys were performed by anti-dengue IgM-capture immunoassay (MAC-ELISA). The results showed that the incidence rates for symptomatic and asymptomatic infections were determined to be 5.7 and 18.6 per 100,000 persons/day (p/d), respectively. The incidence rate of symptomatic infections was significantly higher in persons <15 year-old than that found in subjects ≥15 years (15.8 versus 2.9 per 100,000 p/d). On the other hand, the incidence rates of asymptomatic infections in both age groups were similar (17.3 and 18.9 per 100,000 p/d, respectively). All four DENV serotypes were detected in three of the four "barrios" studied. Finally, age and hyperendemicity were probably the contributing factors to the incidence of dengue in the four "barrios" investigated. Surely, the asymptomatic infections contributed to increase the viral transmission in the study area.

Dengue virus infections in a cohort of schoolchildren from Maracay, Venezuela: a 2-year prospective study.

In 2001, we began a prospective longitudinal study in a cohort of schoolchildren 5-13 years of age residing in Maracay, Venezuela, to determine the cumulative incidence of dengue virus (DENV) infections by virus serotype. This report presents serological data from 710 schoolchildren who were tested during the first 2 years of the study. Serological evaluations were conducted by plaque reduction neutralization test (PRNT). At study initiation, 51% of children had PRNT antibody titers against one (30.1% = 13.4% DENV-1, 14.2% DENV-2, 0.6% DENV-3, and 2% DENV-4) or multiple DENV serotypes (20.9%). By the end of the first year, 89 of 348 (25.6%) PRNT-negative children seroconverted, and 94 of 362 (26%) who were PRNT-positive in their baseline sera tested positive for additional serotypes, for an overall cumulative incidence of DENV infections of 25.8%. By serotype, the percentages found were 1.4% DENV-1, 1.4% DENV-2, 19% DENV-3, and 1.2% DENV-4. In the second year, 37 of 259 (14.3%) PRNT-negative children seroconverted, and 83 of 451 (18.4%) who had monotypic and multitypic PRNT patterns in their baseline sera exhibited additional serotype seroconversions, for an overall cumulative incidence of DENV infections of 16.9%. By serotype, the percentages found were 0.8% DENV-1, 1.5% DENV-2, 8.5% DENV-3, and 2.3% DENV-4. Overall, these results suggest a high cumulative incidence of DENV infections among 5-13-year-old school children in Maracay, Venezuela.

[Laboratory diagnosis of dengue virus infections in Aragua State, Venezuela: October 1997-December 1998]. / Diagnóstico de laboratorio de infecciones por el virus dengue en el estado Aragua; Venezuela: Octubre 1997-Diciembre 1998.

The efficacy of a proactive dengue surveillance system to predict epidemics depends on the laboratory diagnostic capacity for an early detection of virus circulation. This study shows the results of the dengue virologic and serologic surveillance accomplished in Aragua State (Venezuela) from October 1997 to December 1998. Five hundred and forty seven sera from suspected dengue patients were tested using the techniques of Virus Isolation and Immunofluorescence Serotyping (VIIS), Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR), Anti-dengue IgM Capture Enzyme Immunoassay (MAC-ELISA) and Haemagglutination Inhibition test (HI). Of the tested sera, 97.4% resulted positive to at least one technique; of these, 60.4% were classified as confirmed cases (virologically positives) and 39.6% as probable cases (virologically negatives/serologically positives). Though the majority of positive cases occurred during the 1997 and 1998 epidemic periods, the gradual increase of the seropositive rates between both periods suggested the incoming 1998 outbreak. Den-1 (51.2%), Den-2 (37.9%) and Den-4 (10.6%) infected patients were detected as well as one dual infection of Den-2 and Den-4 (0.3%). Dengue hyperendemicity (co-circulation of Den-1, Den-2 and Den-4) in Aragua State was confirmed together with the detection of few cases (6.5%) of Dengue Hemorrhagic Fever/Dengue Shock Syndrome cases (HF/DSS); 38.1% of these cases occurred in patients with secondary infections. The high percentage (85.7%) of DHF/DSS cases infected by Den-2 virus supports the reported virulence of this serotype.